The bioanalysis of peptide-based therapeutics includes a measurement of the concentration, structure, and activity of peptides within biological fluids such as blood, plasma, and urine.
Aliri has over a decade of experience supporting regulatory drug development for therapeutic peptides of all classes, including GLP-1 analogs. There are many challenges of analyzing peptides, such as non-specific binding, clinically significant limits of detection, and stability. We have developed strong processes to overcome these challenges, employing the techniques below to give sponsors a better understanding of how their molecule behaves in the body and to ensure its efficacy and safety:
